Company intelligence / Profile preview

Lokavant

New York, New York, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Lokavant does not develop therapeutics but offers a platform leveraging AI, machine learning, and data from more than 2,000 proprietary and 500,000 public clinical trials to provide predictive analytics for clinical trial planning and execution, aiming to reduce costs and improve study outcomes for sponsors and CROs[1][2][4][5].

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

ParexelCMIC Group

Beyond the preview

Go deeper on Lokavant.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lokavant.

Explore the full profile